Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether NHS Blood and Transplant has made an assessment of the potential impact of the use of tanning injections more than (a) 12 months (b) three months prior to donating on blood safety.

The safety of blood is of the upmost importance. Patients that receive blood donations can be particularly vulnerable to infections. In the United Kingdom, the Blood Safety and Quality Regulations 2005 mandate permanent deferral from blood donation for anyone with a history of non-prescribed intravenous or intramuscular drug use. The Blood Safety and Quality Regulations 2005 are available at the following link:

https://www.legislation.gov.uk/uksi/2005/50/schedule/part/3/paragraph/2n3

This includes those in receipt of tanning injections, for any period prior to donation. NHS Blood and Transplant has provided guidance on blood safety by the Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC). JPAC guidance reflects the Blood Safety and Quality Regulations 2005 in the Addiction and Drug Abuse guideline and the Blood Safety Entry guideline, which are available, respectively, at the following two links:

https://transfusionguidelines.org/dsg/wb/guidelines/ad001-addiction-and-drug-abuse

https://www.transfusionguidelines.org/dsg/wb/guidelines/bl008-blood-safety-entry

Injections can carry a risk of blood-borne illness. To preserve the safety of patients who receive blood donations, measures are taken to reduce the risk of transmitting blood-borne infections, including cleanliness and safety standards. However, as tanning injections are not well regulated, measures that would normally be used to prevent blood-borne infection cannot be assessed.